Paying users area
Try for free
AbbVie Inc. pages available for free this week:
- Income Statement
- Balance Sheet: Liabilities and Stockholders’ Equity
- Common-Size Income Statement
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Long-term (Investment) Activity Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Selected Financial Data since 2012
- Return on Assets (ROA) since 2012
- Current Ratio since 2012
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get 1-month access to AbbVie Inc. for $24.99, or
get full access to the entire website for at least 3 months from $62.19.
This is a one-time payment. There is no automatic renewal.
We accept:
Inventory Disclosure
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Finished goods | |||||||||||
Work-in-process | |||||||||||
Raw materials | |||||||||||
Inventories |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Item | Description | The company |
---|---|---|
Inventories | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. | AbbVie Inc. inventories increased from 2021 to 2022 and from 2022 to 2023. |